Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 5Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Head & Neck 3Tumor-Agnostic 2Lymphoid 2Other solid neoplasm 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 1Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × SHR-1701 × Thoracic × Clear all
NCT04580498 2023-05-19

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
107 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05177497 2022-01-04

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

Shanghai Chest Hospital

Phase 2 Unknown
19 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Unknown
561 enrolled
Thoracic

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer

NCT04884009 2021-05-12

A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
106 enrolled
Thoracic

Lung Neoplasms

NCT04560244 2020-09-23

A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment

Shandong Cancer Hospital and Institute

Phase 2 Unknown
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡